WO2006002840A3 - Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel - Google Patents
Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel Download PDFInfo
- Publication number
- WO2006002840A3 WO2006002840A3 PCT/EP2005/006865 EP2005006865W WO2006002840A3 WO 2006002840 A3 WO2006002840 A3 WO 2006002840A3 EP 2005006865 W EP2005006865 W EP 2005006865W WO 2006002840 A3 WO2006002840 A3 WO 2006002840A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- propellant
- formulations containing
- suspension formulations
- aerosol suspension
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA06015204A MXPA06015204A (es) | 2004-07-02 | 2005-06-25 | Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores. |
JP2007518518A JP5209963B2 (ja) | 2004-07-02 | 2005-06-25 | 噴霧剤としてtg227ea又はtg134aを含有するエアロゾル懸濁製剤 |
KR1020077002760A KR101297061B1 (ko) | 2004-07-02 | 2005-06-25 | 추진제로서 tg 227 ea 또는 tg 134 a를함유하는 에어로졸 현탁액 제형 |
NZ552869A NZ552869A (en) | 2004-07-02 | 2005-06-25 | Aerosol suspension formulations containing TG 227 ea as a propellant, an ipratropium or tiotropium salt and a small amount of free water to stabilise the composition |
EP05761637.7A EP1809243B2 (de) | 2004-07-02 | 2005-06-25 | Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel |
CA2571519A CA2571519C (en) | 2004-07-02 | 2005-06-25 | Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant |
DK05761637.7T DK1809243T4 (da) | 2004-07-02 | 2005-06-25 | Aerosolsuspensionsformuleringer med tg 227 ea som drivmiddel |
ES05761637T ES2391563T5 (es) | 2004-07-02 | 2005-06-25 | Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor |
BRPI0512878-1A BRPI0512878A (pt) | 2004-07-02 | 2005-06-25 | formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor |
AU2005259523A AU2005259523B2 (en) | 2004-07-02 | 2005-06-25 | Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant |
EA200700042A EA013428B1 (ru) | 2004-07-02 | 2005-06-25 | РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА |
PL05761637.7T PL1809243T5 (pl) | 2004-07-02 | 2005-06-25 | Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy |
IL180461A IL180461A0 (en) | 2004-07-02 | 2006-12-31 | Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant |
NO20070373A NO20070373L (no) | 2004-07-02 | 2007-01-19 | Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004032322.4 | 2004-07-02 | ||
DE102004032322A DE102004032322A1 (de) | 2004-07-02 | 2004-07-02 | Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel |
DE102005023334.1 | 2005-05-17 | ||
DE200510023334 DE102005023334A1 (de) | 2005-05-17 | 2005-05-17 | Aeorosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2006002840A2 WO2006002840A2 (de) | 2006-01-12 |
WO2006002840A3 true WO2006002840A3 (de) | 2006-11-16 |
WO2006002840A8 WO2006002840A8 (de) | 2012-11-08 |
Family
ID=35169696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/006865 WO2006002840A2 (de) | 2004-07-02 | 2005-06-25 | Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel |
Country Status (19)
Country | Link |
---|---|
US (1) | US8357352B2 (de) |
EP (1) | EP1809243B2 (de) |
JP (1) | JP5209963B2 (de) |
KR (1) | KR101297061B1 (de) |
AR (1) | AR049660A1 (de) |
AU (1) | AU2005259523B2 (de) |
BR (1) | BRPI0512878A (de) |
CA (1) | CA2571519C (de) |
DK (1) | DK1809243T4 (de) |
EA (1) | EA013428B1 (de) |
EC (1) | ECSP077126A (de) |
ES (1) | ES2391563T5 (de) |
IL (1) | IL180461A0 (de) |
MX (1) | MXPA06015204A (de) |
NO (1) | NO20070373L (de) |
NZ (1) | NZ552869A (de) |
PL (1) | PL1809243T5 (de) |
TW (1) | TWI377943B (de) |
WO (1) | WO2006002840A2 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA013428B1 (ru) | 2004-07-02 | 2010-04-30 | Бёрингер Ингельхайм Интернациональ Гмбх | РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА |
GB0501956D0 (en) * | 2005-01-31 | 2005-03-09 | Arrow Internat | Nebulizer formulation |
DE102006053374A1 (de) * | 2006-02-09 | 2007-08-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz |
DE102006017320A1 (de) * | 2006-04-11 | 2007-10-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel |
US20070286814A1 (en) * | 2006-06-12 | 2007-12-13 | Medispray Laboratories Pvt. Ltd. | Stable aerosol pharmaceutical formulations |
WO2008047239A2 (en) * | 2006-09-21 | 2008-04-24 | Medispray Laboratories Pvt. Ltd. | Stable aerosol pharmaceutical formulations |
GB2442745B (en) * | 2006-10-13 | 2011-04-06 | At & T Corp | Method and apparatus for acoustic sensing using multiple optical pulses |
GB2442746B (en) * | 2006-10-13 | 2011-04-06 | At & T Corp | Method and apparatus for acoustic sensing using multiple optical pulses |
EP2077132A1 (de) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung |
EP2393491B1 (de) * | 2009-02-03 | 2020-04-22 | Microbion Corporation | Bismutthiole als antiseptika für epithelgewebe, akute und chronische wunden, bakterielle biofilme und andere anwendungsgebiete |
WO2010112358A2 (de) | 2009-03-31 | 2010-10-07 | Boehringer Ingelheim International Gmbh | Verfahren zur beschichtung einer oberfläche eines bauteils |
EP3508239B1 (de) | 2009-05-18 | 2020-12-23 | Boehringer Ingelheim International GmbH | Adapter, inhalationseinrichtung und zerstäuber |
EP2504052B1 (de) | 2009-11-25 | 2022-07-27 | Boehringer Ingelheim International GmbH | Zerstäuber |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
EP2504051B1 (de) | 2009-11-25 | 2019-09-04 | Boehringer Ingelheim International GmbH | Zerstäuber |
JP5874724B2 (ja) | 2010-06-24 | 2016-03-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
WO2013127738A1 (de) | 2012-02-28 | 2013-09-06 | Boehringer Ingelheim International Gmbh | Neue treibgashaltige tiotropium-formulierung |
WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
JP6643231B2 (ja) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
HRP20220596T1 (hr) | 2014-05-07 | 2022-06-24 | Boehringer Ingelheim International Gmbh | Raspršivač |
WO2015169732A1 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Container, nebulizer and use |
DK3139984T3 (da) | 2014-05-07 | 2021-07-19 | Boehringer Ingelheim Int | Forstøver |
US10322198B2 (en) | 2016-07-08 | 2019-06-18 | The Procter & Gamble Company | Freshening compositions comprising isopropyl myristate |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993015741A1 (en) * | 1992-02-06 | 1993-08-19 | Glaxo Group Limited | Medicaments |
US5955058A (en) * | 1992-12-09 | 1999-09-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Stabilized medicinal aerosol solution formulations containing ipratropium bromide |
WO2002005785A1 (en) * | 2000-07-18 | 2002-01-24 | Aeropharm Technology Incorporated | Modulated release therapeutic aerosols |
WO2004084858A2 (en) * | 2003-03-20 | 2004-10-07 | Boehringer Ingelheim Pharmaceuticals, Inc. | Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants |
EP1527772A1 (de) * | 2003-10-30 | 2005-05-04 | Laboratorio Pablo Cassara S.r.L. | Eine pharmazeutische Aerosollösungformulierung verwendbar für die Mund- oder nasale Einatmung, welche aufbewahrungsstabile Glukocorticoide enthält; Methode für das Stabilisieren von Formulierungen und Gebrauch eines Stabilizators |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8824804D0 (en) | 1988-10-22 | 1988-11-30 | Fisons Plc | Device |
US5225183A (en) | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
DE4003270A1 (de) | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgase und ihre verwendung in arzneimittelzubereitungen |
US5919435A (en) | 1990-11-09 | 1999-07-06 | Glaxo Group Limited | Aerosol formulation containing a particulate medicament |
IL104068A (en) | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
ES2140943T3 (es) | 1993-04-30 | 2000-03-01 | Minnesota Mining & Mfg | Configuracion de cierre hermetico para botes de aerosol. |
WO1995002651A1 (en) | 1993-07-15 | 1995-01-26 | Minnesota Mining And Manufacturing Company | Seals for use in an aerosol delivery device |
HUP9800641A3 (en) | 1995-04-14 | 2001-04-28 | Glaxo Wellcome Inc Res Triangl | Metered dose inhaler for beclomethasone dipropionate |
GB9513084D0 (en) | 1995-06-27 | 1995-08-30 | Bespak Plc | Dispensing apparatus |
SE9701750D0 (sv) | 1997-05-12 | 1997-05-12 | Astra Pharma Prod | Inhalation device and method of manufacture thereof |
GB2326334A (en) | 1997-06-13 | 1998-12-23 | Chiesi Farma Spa | Pharmaceutical aerosol compositions |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
JP3801348B2 (ja) | 1997-07-28 | 2006-07-26 | 株式会社ヴァレオサーマルシステムズ | レシーバタンク |
JP4117059B2 (ja) * | 1998-02-10 | 2008-07-09 | 東洋エアゾール工業株式会社 | 高濃度粉末エアゾール製品 |
US6423298B2 (en) | 1998-06-18 | 2002-07-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
ATE234604T1 (de) | 1998-08-04 | 2003-04-15 | Jago Res Ag | Medizinische aerosolformulierungen |
US5955958A (en) † | 1998-10-05 | 1999-09-21 | Lu; Kai | Holiday candy jar with light and sound effects |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
IT1303788B1 (it) | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
US6261539B1 (en) * | 1998-12-10 | 2001-07-17 | Akwete Adjei | Medicinal aerosol formulation |
US6739333B1 (en) * | 1999-05-26 | 2004-05-25 | Boehringer Ingelheim Pharma Kg | Stainless steel canister for propellant-driven metering aerosols |
GB0002798D0 (en) | 2000-02-09 | 2000-03-29 | Glaxo Group Ltd | Actuator nozzle for metered dose inhaler |
CA2417973A1 (en) * | 2000-08-04 | 2002-02-14 | Longwood Pharmaceutical Research, Inc. | Formulations of mometasone and a bronchodilator for pulmonary administration |
DE10043509A1 (de) | 2000-09-01 | 2002-03-14 | Asta Medica Ag | Feste Peptidzubereitungen für die Inhalation und deren Herstellung |
US7776315B2 (en) | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
EP1241113A1 (de) | 2001-03-12 | 2002-09-18 | CHIESI FARMACEUTICI S.p.A. | Inhalator mit Mitteln um chemische Stabilität der darin enthaltenen medizinischen Aerosollösung zu verbessern |
DE60239806D1 (de) | 2001-06-26 | 2011-06-01 | Norton Healthcare Ltd | Verbesserter aerosol-regler |
CA2474690A1 (en) | 2002-02-01 | 2003-08-07 | Astrazeneca Ab | Composition for inhalation |
EP1340492A1 (de) | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung |
WO2003074024A1 (en) | 2002-03-01 | 2003-09-12 | Chiesi Farmaceutici S.P.A | Formoterol superfine formulation |
DE10214263A1 (de) † | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum |
DK1565422T3 (da) | 2002-11-22 | 2009-04-06 | Lilly Co Eli | Vitamin-D-receptor-modulatorer |
EA013428B1 (ru) | 2004-07-02 | 2010-04-30 | Бёрингер Ингельхайм Интернациональ Гмбх | РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА |
DE102004032322A1 (de) | 2004-07-02 | 2006-02-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel |
EP2311793A1 (de) | 2004-12-17 | 2011-04-20 | Cipla Ltd. | Kristallines Levosalbutamol-sulphate (Form II) |
DE102006053374A1 (de) | 2006-02-09 | 2007-08-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz |
DE102006017320A1 (de) | 2006-04-11 | 2007-10-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel |
-
2005
- 2005-06-25 EA EA200700042A patent/EA013428B1/ru not_active IP Right Cessation
- 2005-06-25 NZ NZ552869A patent/NZ552869A/en unknown
- 2005-06-25 ES ES05761637T patent/ES2391563T5/es active Active
- 2005-06-25 MX MXPA06015204A patent/MXPA06015204A/es active IP Right Grant
- 2005-06-25 EP EP05761637.7A patent/EP1809243B2/de active Active
- 2005-06-25 AU AU2005259523A patent/AU2005259523B2/en active Active
- 2005-06-25 JP JP2007518518A patent/JP5209963B2/ja active Active
- 2005-06-25 KR KR1020077002760A patent/KR101297061B1/ko active IP Right Grant
- 2005-06-25 WO PCT/EP2005/006865 patent/WO2006002840A2/de active Application Filing
- 2005-06-25 CA CA2571519A patent/CA2571519C/en not_active Expired - Fee Related
- 2005-06-25 BR BRPI0512878-1A patent/BRPI0512878A/pt not_active IP Right Cessation
- 2005-06-25 PL PL05761637.7T patent/PL1809243T5/pl unknown
- 2005-06-25 DK DK05761637.7T patent/DK1809243T4/da active
- 2005-06-29 US US11/169,876 patent/US8357352B2/en active Active
- 2005-07-01 AR ARP050102757A patent/AR049660A1/es unknown
- 2005-07-01 TW TW094122245A patent/TWI377943B/zh active
-
2006
- 2006-12-31 IL IL180461A patent/IL180461A0/en unknown
-
2007
- 2007-01-02 EC EC2007007126A patent/ECSP077126A/es unknown
- 2007-01-19 NO NO20070373A patent/NO20070373L/no unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993015741A1 (en) * | 1992-02-06 | 1993-08-19 | Glaxo Group Limited | Medicaments |
US5955058A (en) * | 1992-12-09 | 1999-09-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Stabilized medicinal aerosol solution formulations containing ipratropium bromide |
WO2002005785A1 (en) * | 2000-07-18 | 2002-01-24 | Aeropharm Technology Incorporated | Modulated release therapeutic aerosols |
WO2004084858A2 (en) * | 2003-03-20 | 2004-10-07 | Boehringer Ingelheim Pharmaceuticals, Inc. | Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants |
EP1527772A1 (de) * | 2003-10-30 | 2005-05-04 | Laboratorio Pablo Cassara S.r.L. | Eine pharmazeutische Aerosollösungformulierung verwendbar für die Mund- oder nasale Einatmung, welche aufbewahrungsstabile Glukocorticoide enthält; Methode für das Stabilisieren von Formulierungen und Gebrauch eines Stabilizators |
Non-Patent Citations (1)
Title |
---|
WILLIAMS R O ET AL: "INFLUENCE OF METERING CHAMBER VOLUME AND WATER LEVEL ON THE EMITTED DOSE OF A SUSPENSION-BASED PDMI CONTAINING PROPELLANT 134A", PHARMACEUTICAL RESEARCH, NEW YORK, NY, US, vol. 14, no. 4, 1997, pages 438 - 443, XP002907568, ISSN: 0724-8741 * |
Also Published As
Publication number | Publication date |
---|---|
NZ552869A (en) | 2010-06-25 |
DK1809243T4 (da) | 2022-09-05 |
ES2391563T5 (es) | 2022-10-26 |
NO20070373L (no) | 2007-01-31 |
EP1809243B2 (de) | 2022-06-08 |
EA200700042A1 (ru) | 2007-08-31 |
JP2008504325A (ja) | 2008-02-14 |
PL1809243T3 (pl) | 2013-05-31 |
US8357352B2 (en) | 2013-01-22 |
WO2006002840A8 (de) | 2012-11-08 |
CA2571519A1 (en) | 2006-01-12 |
TWI377943B (en) | 2012-12-01 |
ECSP077126A (es) | 2007-02-28 |
EP1809243B8 (de) | 2013-02-27 |
AU2005259523A1 (en) | 2006-01-12 |
ES2391563T3 (es) | 2012-11-27 |
JP5209963B2 (ja) | 2013-06-12 |
CA2571519C (en) | 2013-05-14 |
EA013428B1 (ru) | 2010-04-30 |
BRPI0512878A (pt) | 2008-04-15 |
WO2006002840A2 (de) | 2006-01-12 |
DK1809243T3 (da) | 2012-10-15 |
AU2005259523B2 (en) | 2011-06-09 |
PL1809243T5 (pl) | 2022-12-27 |
KR20070042166A (ko) | 2007-04-20 |
MXPA06015204A (es) | 2007-03-15 |
TW200612945A (en) | 2006-05-01 |
US20060002863A1 (en) | 2006-01-05 |
EP1809243B1 (de) | 2012-07-18 |
IL180461A0 (en) | 2007-06-03 |
EP1809243A2 (de) | 2007-07-25 |
KR101297061B1 (ko) | 2013-08-19 |
AR049660A1 (es) | 2006-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006002840A3 (de) | Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel | |
ZA200305993B (en) | Herbicidal compositions. | |
WO2006056696A3 (fr) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation | |
ZA200409617B (en) | Microcapsule formulations. | |
WO2007067044A3 (en) | Modified active-ingredient-containing pellets/capsules | |
WO2002012166A3 (en) | Triamine derivative melanocortin receptor ligands and methods of using same | |
EG25171A (en) | Herbicide compositions. | |
ZA200308717B (en) | Herbicidal composition. | |
AP2005003195A0 (en) | Herbicidal compositions. | |
WO2007002823A3 (en) | Formulations of conjugated estrogens and bazedoxifene | |
ZA200201862B (en) | Electrostatic aerosol compositions. | |
MXPA03009002A (es) | 5-halogeno-6-fenil-7-fluoroalquilamino-triazolopirimidinas. | |
ZA200501387B (en) | Antimicrobial compositions. | |
ZA200210279B (en) | Herbicidal compositions. | |
ZA200306923B (en) | Fungicide compositions. | |
MXPA03009315A (es) | 1.3-dionas carbociclicas tiazolil-substituidas como agentes pesticidas. | |
UA89789C2 (ru) | Суспензионные композиции, которые распыливаются в виде аэрозоля, с tg 227 еа или tg 134а в качестве пропеллента | |
WO2005060981A3 (en) | Pharmaceutical compositions | |
MXPA01005595A (es) | Nuevas coposiones herbicidas. | |
WO2004043366A3 (en) | Sulfonamides | |
ZA200109902B (en) | Stable biocidal compositions. | |
WO2002078641A3 (en) | Pyrrolidine sulfonamides | |
WO2004043368A3 (en) | Sulfonamides | |
WO2004043369A3 (en) | Sulfonamides | |
WO2004043463A3 (en) | Sulfonamides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200609718 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 7638/DELNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/015204 Country of ref document: MX Ref document number: 2571519 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12006502636 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007518518 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 180461 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 07000240 Country of ref document: CO |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580023820.1 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 552869 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005259523 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077002760 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200700042 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005761637 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2005259523 Country of ref document: AU Date of ref document: 20050625 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005259523 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005761637 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0512878 Country of ref document: BR |